Exploring ketogenic diet resistance in glucose transporter type 1 deficiency syndrome: A comprehensive review and critical appraisal
Abstract Glucose transporter type 1 deficiency syndrome (GLUT1DS) commonly presents with early‐onset epilepsy that often resists conventional pharmacological treatment. Ketogenic diet therapy (KDT) is the preferred approach to address the underlying metabolic anomaly. However, a subset of GLUT1DS pa...
Saved in:
Main Authors: | Raffaele Falsaperla, Vincenzo Sortino, Gerhard Josef Kluger, Thomas Herberhold, Andrea Rüegger, Pasquale Striano, Martino Ruggieri, Joerg Klepper, Georgia Ramantani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.13110 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
D,L‐3‐hydroxybutyrate in the treatment of glucose transporter 1 deficiency syndrome (Glut1DS)
by: Aya Amer, et al.
Published: (2025-01-01) -
Decanoic acid-enriched ketogenic diet in refractory epilepsy
by: Hui Jin Shin, et al.
Published: (2025-01-01) -
Ketogenic diets and Alzheimer’s disease
by: Klaus W. Lange, et al.
Published: (2017-03-01) -
Impact of the Ketogenic Diet on Neurological Diseases: A Review
by: Carmen Rubio, et al.
Published: (2025-01-01) -
Possible impact of use of a ketogenic diet in pregnancy on the fetus: Review of animal and human studies
by: Agata Miłosz, et al.
Published: (2025-03-01)